封面
市場調查報告書
商品編碼
1532578

精子庫市場,按服務類型(精子儲存、精液分析、基因諮詢)、按捐贈者(已知、匿名、身份披露)、按技術(捐贈者授精、試管受精)、按最終用途(醫院、診所、生育中心) - 預測(2024 - 2032)

Sperm Bank Market, By Service Type (Sperm Storage, Semen Analysis, Genetic Consultation), By Donor (Known, Anonymous, ID Disclosure), By Technique (Donor Insemination, IVF), By End-use (Hospitals, Clinics, Fertility Centers) - Forecast (2024 - 2032)

出版日期: | 出版商: Global Market Insights Inc. | 英文 180 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

在不孕症盛行率上升的推動下,精子庫市場規模在 2024 年至 2032 年期間將呈現 3.8% 的複合年成長率。據世界衛生組織稱,大約 17.5% 的成年人,即全世界大約六分之一的人患有不孕症。全球約 10-15% 的夫婦患有不孕症,生育延遲、生活方式改變、環境影響和健康狀況等因素導致不孕症的發生。這導致對輔助生殖技術(ART)和生育治療的需求增加。精子捐贈、保存和遺傳諮詢等服務利用率的提高正在刺激市場成長。

增強型冷凍保存技術正在徹底改變精子庫產業,從而改善精子樣本的保存和儲存。這些進步包括玻璃化方法的發展,該方法可以最大限度地減少冰晶的形成並減少冷凍過程中的細胞損傷。此外,冷凍保護劑解決方案的創新為精子細胞提供了更好的保護,增強了其解凍後的活力。自動冷凍和解凍系統也變得越來越普遍,以確保一致和最佳的保存條件。這些改進透過維持保存的精子的更高品質和活力,顯著提高了輔助生殖技術 (ART) 的成功率。

精子庫產業根據服務類型、捐贈者、技術、最終用途和地區進行分類。

到 2032 年,遺傳諮詢領域將快速成長,因為這項服務對於擔心將遺傳性疾病遺傳給孩子的個人和夫婦至關重要。透過提供全面的基因篩檢和諮詢,精子庫可以幫助客戶做出明智的決定並選擇具有良好遺傳特徵的捐贈者。這不僅提高了 ART 手術的安全性和成功率,也滿足了生殖健康領域對個人化和精準醫療日益成長的需求。

到 2032 年,診所部門將快速擴張,因為他們與精子銀行合作提供一系列服務,包括精子捐贈、子宮內授精 (IUI)、體外受精 (IVF) 和基因篩檢。精子庫和生育診所之間的合作關係確保客戶獲得從初步諮詢到成功受孕的全面護理。診所利用精子銀行在捐贈者招募、篩選和保存方面的專業知識,為患者提供高品質的生育解決方案。全球生育診所數量不斷增加,加上其先進的基礎設施和熟練的醫療保健專業人員,有利於市場前景。

在支持性監管框架、ART 程序的高度接受度和先進的醫療基礎設施的推動下,歐洲精子庫產業將在 2032 年之前穩定成長。英國、丹麥和西班牙等國家處於領先地位,提供最先進的生育服務並吸引來自該地區及其他地區的客戶。對研發的高度重視,以及旨在改善 ART 效果和擴大可用治療範圍的大量臨床研究和試驗,將促進產業成長。

目錄

第 1 章:方法與範圍

第 2 章:執行摘要

第 3 章:產業洞察

  • 產業生態系統分析
  • 產業影響力
    • 成長動力
      • 對輔助生殖技術(ART)的需求不斷增加
      • 提高意識和教育舉措
      • 不斷成長的教育和職業追求正在推遲生育
    • 產業陷阱與挑戰
      • 嚴格的監管環境
      • 與這些服務相關的高成本
  • 成長潛力分析
  • 技術景觀
  • 監管環境
  • 波特的分析
  • PESTEL分析

第 4 章:競爭格局

  • 介紹
  • 公司矩陣分析
  • 主要市場參與者的競爭分析
  • 競爭定位矩陣
  • 戰略展望矩陣

第 5 章:市場估計與預測:按服務類型,2021 - 2032 年

  • 主要趨勢
  • 精子儲存
  • 精液分析
  • 遺傳諮詢

第 6 章:市場估計與預測:按捐贈者分類,2021 - 2032 年

  • 主要趨勢
  • 已知捐贈者
  • 匿名捐贈者
  • 身分揭露捐贈者

第 7 章:市場估計與預測:按技術分類,2021 - 2032 年

  • 主要趨勢
  • 捐贈者授精
  • 體外受精

第 8 章:市場估計與預測:按最終用途,2021 - 2032 年

  • 主要趨勢
  • 醫院和診所
  • 生育診所和中心
  • 研究所和實驗室
  • 其他最終用戶

第 9 章:市場估計與預測:按地區,2021 - 2032

  • 主要趨勢
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 荷蘭
    • 歐洲其他地區
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 亞太地區其他地區
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 拉丁美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 南非
    • 阿拉伯聯合大公國
    • 中東和非洲其他地區

第 10 章:公司簡介

  • California Cryobank
  • CryoChoice
  • CryoGam Colorado
  • Cryos International
  • European Sperm Bank
  • Fairfax Cryobank
  • Fairfax Cryobank
  • London Sperm Bank
  • Manhattan Cryobank
  • Midwest Sperm Bank
  • New England Cryogenic Center
  • NW Cryobank
  • Seattle Sperm Bank
  • The Sperm Bank of California
  • Xytex
簡介目錄
Product Code: 9633

The Sperm Bank Market size will exhibit 3.8% CAGR during 2024-2032, driven by the rising prevalence of infertility. According to WHO, approximately 17.5% of the adult population, or roughly 1 in 6 individuals worldwide, experience infertility. Infertility affects approximately 10-15% of couples globally, with factors such as delayed parenthood, lifestyle changes, environmental influences, and health conditions contributing to the incidence. This has led to a heightened demand for assisted reproductive technologies (ART) and fertility treatments. Increased utilization of services, including sperm donation, preservation, and genetic consultation is stimulating the market growth.

Enhanced cryopreservation techniques are revolutionizing the sperm bank industry, leading to improved preservation and storage of sperm samples. These advancements include the development of vitrification methods, which minimize ice crystal formation and reduce cellular damage during the freezing process. Additionally, innovations in cryoprotectant solutions are providing better protection for sperm cells, enhancing their viability upon thawing. Automated freezing and thawing systems are also becoming more prevalent, ensuring consistent and optimal preservation conditions. These improvements are significantly increasing the success rates of assisted reproductive technologies (ART) by maintaining higher quality and motility of preserved sperm.

The sperm bank industry is classified based on service type, donor, technique, end-use and region.

The genetic consultation segment will grow rapidly through 2032, as this service is crucial for individuals and couples who are concerned about passing on genetic disorders to their children. By providing comprehensive genetic screening and counseling, sperm banks can help clients make informed decisions and choose donors with favorable genetic profiles. This not only enhances the safety and success rates of ART procedures but also addresses the growing demand for personalized and precision medicine in reproductive health.

Clinics segment will expand at a fast pace through 2032, as they collaborate with sperm banks to offer a range of services, including sperm donation, intrauterine insemination (IUI), in vitro fertilization (IVF), and genetic screening. The partnership between sperm banks and fertility clinics ensures that clients receive comprehensive care, from initial consultation to successful conception. Clinics leverage the expertise of sperm banks in donor recruitment, screening, and preservation to provide high-quality fertility solutions to their patients. The increasing number of fertility clinics worldwide, coupled with their advanced infrastructure and skilled healthcare professionals, is favoring the market outlook.

Europe sperm bank industry will grow at a steady pace through 2032, driven by supportive regulatory frameworks, high acceptance of ART procedures, and advanced healthcare infrastructure. Countries such as the United Kingdom, Denmark, and Spain are at the forefront, offering state-of-the-art fertility services and attracting clients from across the region and beyond. A strong emphasis on R&D, with numerous clinical studies and trials aimed at improving ART outcomes and expanding the range of available treatments, will bolster the industry growth.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates & calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing demand for assisted reproductive technologies (ART)
      • 3.2.1.2 Rising awareness and education initiatives
      • 3.2.1.3 Growing educational and career pursuits are delaying childbearing
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 Stringent regulatory landscape
      • 3.2.2.2 High cost associated with these services
  • 3.3 Growth potential analysis
  • 3.4 Technological landscape
  • 3.5 Regulatory landscape
  • 3.6 Porter's analysis
  • 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Competitive analysis of major market players
  • 4.4 Competitive positioning matrix
  • 4.5 Strategy outlook matrix

Chapter 5 Market Estimates and Forecast, By Service Type, 2021 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Sperm storage
  • 5.3 Semen analysis
  • 5.4 Genetic consultation

Chapter 6 Market Estimates and Forecast, By Donor, 2021 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Known donor
  • 6.3 Anonymous donor
  • 6.4 ID disclosure donor

Chapter 7 Market Estimates and Forecast, By Technique, 2021 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 Donor insemination
  • 7.3 In-vitro fertilization

Chapter 8 Market Estimates and Forecast, By End-Use, 2021 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 Hospitals and clinics
  • 8.3 Fertility clinics and centers
  • 8.4 Research institutes and laboratories
  • 8.5 Other end-users

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

  • 9.1 Key trends
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 France
    • 9.3.4 Spain
    • 9.3.5 Italy
    • 9.3.6 Netherlands
    • 9.3.7 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 South Korea
    • 9.4.6 Rest of Asia Pacific
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Argentina
    • 9.5.4 Rest of Latin America
  • 9.6 Middle East and Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 South Africa
    • 9.6.3 UAE
    • 9.6.4 Rest of Middle East and Africa

Chapter 10 Company Profiles

  • 10.1 California Cryobank
  • 10.2 CryoChoice
  • 10.3 CryoGam Colorado
  • 10.4 Cryos International
  • 10.5 European Sperm Bank
  • 10.6 Fairfax Cryobank
  • 10.7 Fairfax Cryobank
  • 10.8 London Sperm Bank
  • 10.9 Manhattan Cryobank
  • 10.10 Midwest Sperm Bank
  • 10.11 New England Cryogenic Center
  • 10.12 NW Cryobank
  • 10.13 Seattle Sperm Bank
  • 10.14 The Sperm Bank of California
  • 10.15 Xytex